Sinusitis

Background

  1. Acute (<4 weeks)
    1. Acute viral
    2. Acute bacterial (0.5-2% of cases)
  2. Subacute (4-12 weeks)
  3. Chronic (>12 weeks)
  4. Other causes
    1. Fungal infections
    2. Allergies

Diagonsis

Classic History & Physical


Viral
Bacterial

Duration (symptoms)

<10days
Usually >10 days OR worsening symptoms within 10 days after initial improvement

Color change (nasal discharge)

+/−
+++, quality usually yellow-green and thick

Maxillary dental pain

+++, often unilateral and associated with a particular sinus

Postnasal drip

More common

Fever, cough, fatigue

More common

Hyposmia/anosmia

More common

Treatment

  • 1. <10 days of symptoms
    • Symptomatic treatment b/c most likely viral
      • Analgesia
      • Mechanical irrigation with buffered, hypertonic saline
      • Topical glucocorticoids
      • Topical decongestants (e.g., oxymetazoline for no more than three days)
      • Antihistamines
      • Mucolytics
  • 2. >10 days or if pt gets better and then worse again (“double sickening”)
    • Mild bacterial sinusitis (pain is mild and temperature <38.3˚C)
      • Another seven days of observation
    • Severe bacterial sinusitis (pain is moderate-severe or temperature ≥38.3˚C)
      • Consider antibiotics
  • If pt is immunocompromised, has underlying condition, or fails observation abx are indicated
  • Obtain CT w/ contrast if concern for complications of sinusitis (e.g. postseptal cellulitis)

Antibiotics

  1. Choice depends on recent antibiotic therapy (past 4-6 weeks)
    1. Amoxicillin 80mg/kg/d x 10-14d
    2. Azithromycin 10mg/kg PO on day 1; then 5mg/kg QD x 5-7d
    3. Cefpodoxime
    4. Cefdinir
    5. Cefuroxime

Antibiotic Failure

  • If initial abx failure occurs consider further workup (e.g. CT) and/or further tx w/ amoxicillin-clavulanate or respiratory fluoroquinolone
  • Nosocomial acute bacterial rhinosinusitis can occur (e.g., after prolonged nasotracheal intubation)
    • Associated with gram-negatives; remove foreign bodies and use culture-directed antibiotic therapy
  • Immunocompromised patients at risk for acute fulminant fungal rhinosinusitis

Source

UpToDate

Tintinalli